Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
More Time For EU Nitrosamine Evaluations Due To COVID-19
Companies Are Allowed Additional Six Months
Mar 27 2020
•
By
Vibha Sharma
Sponsors Have More Time For Nitrosamine-Related Evaluations • Source: Shutterstock
More from Manufacturing
More from Compliance